skip to main content, skip to Quick links, or skip to Search

Veterinary Genetics Laboratory

Contact Information
Phone:
919.513.3314 (please leave message)

If Requesting Swabs Please Email: vcgl@lists.ncsu.edu
Please state your mailing address, how many kits you would like and which test you are requesting (Boxer ARVC, Feline HCM, Doberman DCM, Old English Sheepdog CA, Gordon Setter CA, Newfoundland Dog SAS)

Blood samples: 1-3 mls of blood in an EDTA tube may be submitted.
The sample does not need to be refrigerated during shipment, it is very stable once in the EDTA tube. Please double bag or put in secondary
container to avoid breakage and spills.

Sample may be shipped to:
NCSU - College of Veterinary Medicine
ATTN: Veterinary Genetics Laboratory
Research Bldg. 228
1060 William Moore Dr.
Raleigh, NC 27607

Cat DNA Tests

Boxer Test ARVC

Doberman DCM Test

General Information

Clinical Support and Diagnostic Veterinary Medical Services

Genetic Mutation Testing Service for Doberman Pinscher Dilated Cardiomyopathy

http://www.vetmed.wsu.edu/deptsVCGL/doberman/images/Cass.jpgThe VCGL laboratory has just released a test for the genetic mutation associated with the development of dilated cardiomyopathy in Doberman pinscher dogs. Follow the link below to test information and request forms.

Update on Doberman pinscher dilated Cardiomyopathy (DC)

Doberman pinscher DCM is an adult onset heart muscle disease that can lead to sudden death or the development of congestive heart failure where the dog starts to cough or becomes short of breath.

This is an inherited disease, but it is adult onset. The average age at which clinical signs may be observed or a Holter monitor becomes abnormal is 6 years of age. However, this is widely variant. Some dogs will show it younger and some, not until they are much older!

This disease can affect the electrical system of the heart or the contractility of the heart muscle. Since the disease is adult onset and can start at varying ages, we recommend an annual echocardiogram and Holter monitoring after 3 years of age.